SC 13G/AAMENDMENTCTMXCIK 0001501989

CytomX Therapeutics, Inc.

Name: SEC EDGAR filing 0001172661-24-005044
Creator: CytomX Therapeutics, Inc.
License: https://www.usa.gov/government-works

5%+ passive stake (SC 13G/A) filed November 14, 2024.

Short-form disclosure of beneficial ownership above 5% by passive investors with no control intent.

Filing facts

Accession number: 0001172661-24-005044
Filer: CytomX Therapeutics, Inc.
Ticker: CTMX
CIK: 0001501989
Form type: SC 13G/A
Form description: 5%+ passive stake
Filed at: November 14, 2024
Industry: SIC 2834Pharmaceutical Preparations
Filing size: 85.7 KB
Last verified: August 26, 2026SecFilingDex pulls from EDGAR with daily cadence

Provenance

Authoritative source — SEC EDGAR

https://www.sec.gov/Archives/edgar/data/1501989/000117266124005044/0001172661-24-005044-index.htm ↗

Filer's full EDGAR submission history

EDGAR · CytomX Therapeutics, Inc. (0001501989) ↗

Machine-readable JSON twin (LLM-citation friendly)

/api/filing/0001172661-24-005044.json

SecFilingDex republishes SEC EDGAR data with provenance. EDGAR is the authoritative source. SecFilingDex is independent and not affiliated with the U.S. Securities and Exchange Commission. Nothing on this page constitutes investment, legal, tax, or other professional advice.